Abciximab administration and clinical outcomes after percutaneous intervention for in-stent restenosis

Catheterization and Cardiovascular Interventions

Volumn 56, Issue 2, 2002, Pages 184-187

  Moustapha, Ali ^a   Assali, Abid R ^a   Sdringola, Stefano ^a   Yusuf, S Wamique ^a   Vaughn, William K ^b   Fish, R David ^b   Schroth, George W ^a   Krajcer, Zvonimir ^b   Rosales, Oscar R ^a   Smalling, Richard W ^a   Anderson, H Vernon ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b ST LUKE S EPISCOPAL HOSPITAL   (United States)

Author keywords

Abciximab; In stent restenosis; Percutaneous intervention

Indexed keywords

ABCIXIMAB; FIBRINOGEN RECEPTOR ANTAGONIST;

ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; ATHERECTOMY; CORONARY ARTERY DISEASE; CORONARY STENT; DEATH; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RESTENOSIS;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIBODIES, MONOCLONAL; CORONARY RESTENOSIS; FEMALE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MALE; MIDDLE AGED; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; RETROSPECTIVE STUDIES; STENTS; TREATMENT OUTCOME;

EID: 0036260717     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.10166     Document Type: Article

References (20)

1. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease
2. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease: Stent Restenosis Study Investigators
3. A comparison of coronary-artery stenting with angioplasty for isolated stenosis of the proximal left anterior descending coronary artery
4. Management of restenosis within the Palmaz-Schatz coronary stent: The U.S. multicenter experience
5. Platelet GPIIb-IIIa blockers
6. Histology after stenting of human saphenous vein bypass grafts: Observations from surgically excised grafts 320 days after stent implantation
7. Morphological characteristics of lesion formation and time course of smooth muscle cell proliferation in a porcine proliferative restenosis model
8. In-stent restenosis: The Washington Hospital Center experience
9. Blockade of platelet GP IIb/IIIa receptors as an antithrombotic strategy
10. Platelet glycoprotein IIb/IIIa receptor antagonists in coronary artery disease
11. Effects of platelet glycoprotein IIb/IIIa receptor blockade by a chimeric monoclonal antibody (abciximab) on acute and six-month outcomes after percutaneous transluminal coronary angioplasty for acute myocardial infarction: EPIC Investigators
12. Effect of platelet glycoprotein IIb/IIIa receptor inhibitor, abciximab, with lower heparin dosages on ischemic complications of percutaneous coronary revascularization
13. Long-term protection from myocardial ischemic events in a randomized trial of brief integrin beta 3 blockade with percutaneous coronary intervention: EPIC investigator group
14. Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: Results from a multicenter randomized trial: EPISTENT Investigators
15. Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary intervention
16. Neointimal response following rotational atherectomy compared to balloon angioplasty in a porcine model of coronary in-stent restenosis
17. Device influence on outcome in the treatment of in-stent restenosis with and without radiation: A subanalysis from the WRIST study
18. Coronary artery stent restenosis responds favorably to repeat interventions
19. Percutaneous and surgical interventions for in-stent restenosis: Long-term outcomes and effect of diabetes mellitus
20. Unexpected mortality reduction with abciximab for in-stent restenosis